Literature DB >> 33952596

A SARS-CoV-2 Variant with L452R and E484Q Neutralization Resistance Mutations.

Michelle Verghese1, Becky Jiang2, Naomi Iwai2, Marilyn Mar2, Malaya K Sahoo1, Fumiko Yamamoto1, Kenji O Mfuh2, Jacob Miller3, Hannah Wang1, James Zehnder1, Benjamin A Pinsky1,2,4.   

Abstract

Entities:  

Keywords:  gene sequencing; genome analysis; molecular methods; virology

Mesh：

Year:  2021        PMID： 33952596      PMCID： PMC8218743          DOI： 10.1128/JCM.00741-21

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  6 in total

1.  Multiplex SARS-CoV-2 Genotyping Reverse Transcriptase PCR for Population-Level Variant Screening and Epidemiologic Surveillance.

Authors:  Hannah Wang; Jacob A Miller; Michelle Verghese; Mamdouh Sibai; Daniel Solis; Kenji O Mfuh; Becky Jiang; Naomi Iwai; Marilyn Mar; ChunHong Huang; Fumiko Yamamoto; Malaya K Sahoo; James Zehnder; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

2.  Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

Authors:  Yiska Weisblum; Fabian Schmidt; Fengwen Zhang; Justin DaSilva; Daniel Poston; Julio Cc Lorenzi; Frauke Muecksch; Magdalena Rutkowska; Hans-Heinrich Hoffmann; Eleftherios Michailidis; Christian Gaebler; Marianna Agudelo; Alice Cho; Zijun Wang; Anna Gazumyan; Melissa Cipolla; Larry Luchsinger; Christopher D Hillyer; Marina Caskey; Davide F Robbiani; Charles M Rice; Michel C Nussenzweig; Theodora Hatziioannou; Paul D Bieniasz
Journal:  Elife       Date:  2020-10-28       Impact factor: 8.140

3.  Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.

Authors:  Allison J Greaney; Andrea N Loes; Katharine H D Crawford; Tyler N Starr; Keara D Malone; Helen Y Chu; Jesse D Bloom
Journal:  Cell Host Microbe       Date:  2021-02-08       Impact factor: 21.023

4.  Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.

Authors:  Robert L Gottlieb; Ajay Nirula; Peter Chen; Joseph Boscia; Barry Heller; Jason Morris; Gregory Huhn; Jose Cardona; Bharat Mocherla; Valentina Stosor; Imad Shawa; Princy Kumar; Andrew C Adams; Jacob Van Naarden; Kenneth L Custer; Michael Durante; Gerard Oakley; Andrew E Schade; Timothy R Holzer; Philip J Ebert; Richard E Higgs; Nicole L Kallewaard; Janelle Sabo; Dipak R Patel; Paul Klekotka; Lei Shen; Daniel M Skovronsky
Journal:  JAMA       Date:  2021-02-16       Impact factor: 56.272

5.  The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.

Authors:  Qianqian Li; Jiajing Wu; Jianhui Nie; Li Zhang; Huan Hao; Shuo Liu; Chenyan Zhao; Qi Zhang; Huan Liu; Lingling Nie; Haiyang Qin; Meng Wang; Qiong Lu; Xiaoyu Li; Qiyu Sun; Junkai Liu; Linqi Zhang; Xuguang Li; Weijin Huang; Youchun Wang
Journal:  Cell       Date:  2020-07-17       Impact factor: 41.582

6.  Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.

Authors:  M Alejandra Tortorici; Martina Beltramello; Florian A Lempp; Dora Pinto; Ha V Dang; Laura E Rosen; Matthew McCallum; John Bowen; Andrea Minola; Stefano Jaconi; Fabrizia Zatta; Anna De Marco; Barbara Guarino; Siro Bianchi; Elvin J Lauron; Heather Tucker; Jiayi Zhou; Alessia Peter; Colin Havenar-Daughton; Jason A Wojcechowskyj; James Brett Case; Rita E Chen; Hannah Kaiser; Martin Montiel-Ruiz; Marcel Meury; Nadine Czudnochowski; Roberto Spreafico; Josh Dillen; Cindy Ng; Nicole Sprugasci; Katja Culap; Fabio Benigni; Rana Abdelnabi; Shi-Yan Caroline Foo; Michael A Schmid; Elisabetta Cameroni; Agostino Riva; Arianna Gabrieli; Massimo Galli; Matteo S Pizzuto; Johan Neyts; Michael S Diamond; Herbert W Virgin; Gyorgy Snell; Davide Corti; Katja Fink; David Veesler
Journal:  Science       Date:  2020-09-24       Impact factor: 47.728
  6 in total
  12 in total

Review 1.  Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants.

Authors:  Deepali Gupta; Priyanka Sharma; Mandeep Singh; Mukesh Kumar; A S Ethayathulla; Punit Kaur
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

2.  Competent immune responses to SARS-CoV-2 variants in older adults following two doses of mRNA vaccination.

Authors:  Mladen Jergović; Jennifer L Uhrlaub; Makiko Watanabe; Christine M Bradshaw; Lisa M White; Bonnie J LaFleur; Taylor Edwards; Ryan Sprissler; Michael Worobey; Deepta Bhattacharya; Janko Nikolich-Žugich
Journal:  Nat Commun       Date:  2022-05-24       Impact factor: 17.694

3.  Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants.

Authors:  Lili Li; Meiling Gao; Peng Jiao; Shulong Zu; Yong-Qiang Deng; Dingyi Wan; Yang Cao; Jing Duan; Saba R Aliyari; Jie Li; Yueyue Shi; Zihe Rao; Cheng-Feng Qin; Yu Guo; Genhong Cheng; Heng Yang
Journal:  Cell Biosci       Date:  2022-05-17       Impact factor: 9.584

4.  Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Incidence of the Presumptive B.1.427/B.1.429 Variant Among Healthcare Personnel at a Northern California Academic Medical Center.

Authors:  Karen B Jacobson; Benjamin A Pinsky; Maria E Montez Rath; Hannah Wang; Jacob A Miller; Mehdi Skhiri; John Shepard; Roshni Mathew; Grace Lee; Bryan Bohman; Julie Parsonnet; Marisa Holubar
Journal:  Clin Infect Dis       Date:  2022-03-09       Impact factor: 20.999

5.  Evolution of spike mutations following antibody treatment in two immunocompromised patients with persistent COVID-19 infection.

Authors:  Yotam Bronstein; Amos Adler; Haytham Katash; Ora Halutz; Yair Herishanu; Katia Levytskyi
Journal:  J Med Virol       Date:  2021-11-13       Impact factor: 20.693

Review 6.  Covid-19 vaccines and variants of concern: A review.

Authors:  Ikbel Hadj Hassine
Journal:  Rev Med Virol       Date:  2021-11-09       Impact factor: 11.043

7.  Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions.

Authors:  Mary Hongying Cheng; James M Krieger; Anupam Banerjee; Yufei Xiang; Burak Kaynak; Yi Shi; Moshe Arditi; Ivet Bahar
Journal:  iScience       Date:  2022-02-17

8.  Evaluation of a Rapid and Accessible Reverse Transcription-Quantitative PCR Approach for SARS-CoV-2 Variant of Concern Identification.

Authors:  Priscilla S-W Yeung; Hannah Wang; Mamdouh Sibai; Daniel Solis; Fumiko Yamamoto; Naomi Iwai; Becky Jiang; Nathan Hammond; Bernadette Truong; Selamawit Bihon; Suzette Santos; Marilyn Mar; Claire Mai; Kenji O Mfuh; Jacob A Miller; ChunHong Huang; Malaya K Sahoo; James L Zehnder; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2022-04-25       Impact factor: 11.677

9.  Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients.

Authors:  Zhenkui Hu; Xing Huang; Jianguo Zhang; Shixiang Fu; Daoyin Ding; Zhimin Tao
Journal:  Front Med (Lausanne)       Date:  2022-01-03

10.  SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA.

Authors:  Seth A Hoffman; Cristina Costales; Malaya K Sahoo; Srikanth Palanisamy; Fumiko Yamamoto; ChunHong Huang; Michelle Verghese; Daniel A Solis; Mamdouh Sibai; Aruna Subramanian; Lucy S Tompkins; Philip Grant; Robert W Shafer; Benjamin A Pinsky
Journal:  Emerg Infect Dis       Date:  2021-07-23       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.